Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   
X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

1q rearrangements in multiple myeloma

Written1998-03Christophe Brigaudeau
Laboratory of Hematology, University Hospital, 87000 Limoges, France

(Note : for Links provided by Atlas : click)

Identity

ICD-Topo C420,C421,C424 BLOOD, BONE MARROW, & HEMATOPOIETIC SYS
ICD-Morpho 9732/3 Plasma cell myeloma / Multiple myeloma
Atlas_Id 2056

Clinics and Pathology

Disease multiple myeloma (MM) is a malignant plasma cell proliferation (chronic lymphoproliferative disorder)
Phenotype / cell stem origin phenotype of mature differentiated B-cell, but also with CD56 expression, which origin is not found in normal plasma cell; CD38+, CD40+, CD138+
Etiology differents factors like cytotoxic drugs, ionizing radiation or oncogenic viruses are suspected to induce decondensation of pericentric heterochromatin, which, in turn, favours the formation of triradials, giving rise to 1q extra copies; such could be the case during evolution of multiple myeloma
Epidemiology multiple myeloma's annual incidence: 30/106; mean age: 62 yrs; rearrangements of chromosome 1q are one of the most frequent sructural abnormalitie in MM (16-26% of abnormal cases), but always as a secondary change
Clinics bone pain; susceptibility to infections; renal failure; neurologic dysfonctions
Pathology MM staging:
- stage I: low tumour cell mass; normal Hb; low serum calcium; no bone lesion; low monoclonal Ig rate;
- stage II: fitting neither stage I nor stage III;
- stage III: high tumour cell mass; low Hb and/or high serum calcium and/or advanced lytic bone lesions and/or high monoclonal Ig rate
Evolution multiple myeloma can evolve towards plasma cell leukemia
Prognosis prognosis (highly variable) is according to the staging and other parameters, of which are now the karyotypic findings (see below)

Cytogenetics

Cytogenetics Morphological
  • duplication of all or part of 1q chromosome and whole arm translocation of 1q can result from unbalanced derivative translocation chromosomes, isochromosomes, or jumping translocations; these structural rearrangements are reported as secondary aberrations and associated with tumor progression and advanced disease
  • 1q has been found translocated with telomeres from differents chromosomes partners: 8pter, 9pter, 12qter, 13pter, 15pter, 17qter, 19pter, 19qter, 21pter, 22pter; whole-arm centromere to centromere translocations occurred most frequently between 16p and 1q; the observation that extra copies of 1q occur in patients with decondensation of centromeric heterochromatin suggests that hypomethylation of this region may play a role in the somatic pairing, fragility and formation of triradial configurations involving the long arm of chromosome 1

    • Genes involved and Proteins

    Note the observation of extra copies of 1q suggests a (low-level) gene amplification of genes related to MM biology: the interleukin 6 (IL-6) signaling pathway may possibly be affected by the amplification of the 1q21 region, which is the site of IL-6RA; other genes of interest in this region include C-reactive protein (CRP) and amyloid P component (APCS), both localized to 1q21-23, and pre-B cell leukemia transcription factor 1 (PBX1) in 1q23

    Bibliography

    Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.
    Brigaudeau C, Trimoreau F, Gachard N, Rouzier E, Jaccard A, Bordessoule D, Praloran V
    British journal of haematology. 1997 ; 96 (3) : 594-600.
    PMID 9054668
     
    Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
    Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Solé F, Cuesta B, Gullón A
    Genes, chromosomes & cancer. 1997 ; 18 (2) : 84-93.
    PMID 9115968
     
    Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.
    Laï JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T
    Blood. 1995 ; 85 (9) : 2490-2497.
    PMID 7537117
     
    Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin.
    Sawyer JR, Tricot G, Mattox S, Jagannath S, Barlogie B
    Blood. 1998 ; 91 (5) : 1732-1741.
    PMID 9473240
     
    Cytogenetic findings in 200 patients with multiple myeloma.
    Sawyer JR, Waldron JA, Jagannath S, Barlogie B
    Cancer genetics and cytogenetics. 1995 ; 82 (1) : 41-49.
    PMID 7627933
     

    Citation

    This paper should be referenced as such :
    Brigaudeau, C
    1q rearrangements in multiple myeloma
    Atlas Genet Cytogenet Oncol Haematol. 1998;2(3):86-87.
    Free journal version : [ pdf ]   [ DOI ]
    On line version : http://AtlasGeneticsOncology.org/Anomalies/1qMM2056ID2056.html

    External links

    arrayMap (UZH-SIB Zurich)Topo ( C42) Morph ( 9732/3) -   [auto + random 100 samples .. if exist ]   [tabulated segments]
     
     
    REVIEW articlesautomatic search in PubMed
    Last year articlesautomatic search in PubMed
    All articlesautomatic search in PubMed


    © Atlas of Genetics and Cytogenetics in Oncology and Haematology
    indexed on : Wed Nov 28 16:16:30 CET 2018

    Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

    For comments and suggestions or contributions, please contact us

    jlhuret@AtlasGeneticsOncology.org.